Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 03/09/2010 12284_de.jpg

    Vetter opens new sales office in suburban Chicago

    Vetter is combining its U.S. activities in the emerging pharmaceutical and biotechnology region of Illinois: Vetter has opened a new sales office in suburban Chicago to focus on its strategy of U.S. growth and expansion.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/vetter-opens-new-sales-office-in-suburban-chicago
  • Press release - 03/09/2010 12303_de.jpg

    Brainy worms: Evolution of the cerebral cortex

    Unexpectedly scientists at the European Molecular Biology Laboratory EMBL in Heidelberg Germany have now discovered a true counterpart of the cerebral cortex in an invertebrate a marine worm. Their findings are published today in Cell and give an idea of what the most ancient higher brain centres looked like and what our distant ancestors used them for.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/brainy-worms-evolution-of-the-cerebral-cortex
  • Article - 30/08/2010 12218_de.jpg

    Bodensee Brustzentrum offers effective breast cancer prevention services

    The two Brustzentrum Bodensee (Lake Constance Breast Centre) sites at the Hospital in Constance and the Women’s Hospital in Friedrichshafen have a principal goal: to enable the best possible early detection of all types of breast cancer, to reduce the morbidity and mortality of breast cancer patients and to increase survival rates by offering ultra-modern breast cancer prevention measures.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bodensee-brustzentrum-offers-effective-breast-cancer-prevention-services
  • Dossier - 30/08/2010 12119_de.jpg

    Disease prevention through better diagnostics

    “Classical treatment approaches are not the only way to ensure good health, rehabilitation and care. In fact, it is envisaged that more effective prevention will contribute to halting the development of diseases and maintaining good health. Prevention is designed to prevent health risks and diseases, make them less likely and delay their onset.” (Declaration of the German government; Official Records of Parliament 17/845, 26th February 2010)

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/disease-prevention-through-better-diagnostics
  • Article - 30/08/2010 12172_de.jpg

    Diagnostics for the early detection of cervical cancer

    The Pap test is regarded as the most successful test for cancer ever, and has saved the lives of many women. However, the test is associated with several weaknesses. The Heidelberg-based in vitro diagnostics company mtm laboratories AG develops and commercialises highly sensitive and highly specific immunochemical tests that provide greater reliability. These tests have the potential to revolutionise the early detection of cervical cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/diagnostics-for-the-early-detection-of-cervical-cancer
  • Article - 30/08/2010 12228_de.jpg

    More effective prevention and treatment of diabetic feet

    Dr. med. dent. Hans-Helmut Schmidt has developed a device that enables the effective and hygienic treatment of patients with diabetic foot syndrome DFS. The new device known as DIAPEDES enables diabetic feet to be treated in a closed foot-shaped container under definite clinical conditions. Diabetic feet can smell and look quite unpleasant and the preventive care that this device will offer for many users has been developed with this problem in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/more-effective-prevention-and-treatment-of-diabetic-feet
  • Article - 30/08/2010 12175_de.jpg

    A centre focusing on hepatocellular carcinoma research

    Under its director, Prof. Dr. Peter Schirmacher, the Institute of Pathology at the University of Heidelberg has become a major liver cancer research centre, with a particular focus on hepatocellular carcinoma. The institute is looking for new diagnostic markers and new molecular targets for drugs that have the potential to be used for specifically treating this cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-centre-focusing-on-hepatocellular-carcinoma-research
  • Article - 30/08/2010 12096_de.jpg

    Genetic testing for the prevention of diseases?

    Genetic testing is beginning to play an important role in personalised medicine and is indispensable for the diagnosis and therapy of many diseases. However, the preventive and diagnostic power of many genetic tests is still inferior to traditional diagnostic tests. In addition, commercial genetic tests do not always live up to the claims made about them.

    https://www.gesundheitsindustrie-bw.de/en/article/news/genetic-testing-for-the-prevention-of-diseases
  • Article - 30/08/2010 12229_de.jpg

    How cancer-causing bacteria reached the South Seas in outrigger canoes

    The bacterium Helicobacter pylori causes gastric ulcers and gastric cancer. The prehistoric great migrations of human populations, including the expansion of the Austronesians across the Pacific and Indian Oceans, can be reconstructed in precise detail from the genetic makeup of different Helicobacter strains.

    https://www.gesundheitsindustrie-bw.de/en/article/news/how-cancer-causing-bacteria-reached-the-south-seas-in-outrigger-canoes
  • Article - 29/08/2010 The photo shows a man with glasses and a poster with FRIAS written on it in the background.<br />

    Robert Murphy – intelligent computers and insights into cells

    Will humans, who consist of billions of cells and hundreds of billions of molecules, ever understand their own complexity? Robert F. Murphy, External Senior Fellow at the Freiburg Institute for Applied Sciences (FRIAS), is a pioneer in what is known as computational biology. This discipline uses mathematical and computational methods to investigate the complexity of biological systems. Progress in this discipline is of major importance for…

    https://www.gesundheitsindustrie-bw.de/en/article/news/robert-murphy-intelligent-computers-and-insights-into-cells
  • Press release - 28/08/2010 09570_de.jpg

    Baden-Württemberg Ministry of Economic Affairs to grant ILM additional financial support

    The Baden-Württemberg Ministry of Economic Affairs has granted the Institute of Laser Technology in Medicine and Metrology (ILM) in Ulm additional financial support totalling 582,000 euros from the German government’s “Future Investment Programme”. The funding is to be used to renew and expand the institute’s equipment in 2010.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/baden-wuerttemberg-ministry-of-economic-affairs-to-grant-ilm-additional-financial-support
  • Press release - 26/08/2010 10289_de.jpg

    Visiting professor meets high expectations

    This fall, Professor Hiromitsu Nakauchi, an internationally renowned researcher in the field of stem cells from the University of Tokyo, will assume a visiting professorship at the International Graduate School in Molecular Medicine Ulm.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/visiting-professor-meets-high-expectations
  • Press release - 23/08/2010 08704_de.jpg

    Mystery of nickel allergies solved

    Researchers from the University of Gießen and the Mannheim Medical Faculty along with colleagues from Freiburg, Münster and Munich, have made a fundamental contribution to deciphering the biological mechanisms behind nickel allergies. The results, which might be of great importance for developing innovative preventive and therapeutic approaches, have now been published in the current edition of “Nature Immunology”.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mystery-of-nickel-allergies-solved
  • Article - 23/08/2010 12137_de.jpg

    Antibiotics for the prevention of malaria

    Researchers from Heidelberg and Berlin have shown that if malaria-infected mice are administered an antibiotic, no parasites appear in the blood and the mice are protected from this life-threatening disease. The scientists believe that antibiotics also have the potential to strengthen the human immune system as well as making it possible to provide a natural needle-free vaccination against malaria.

    https://www.gesundheitsindustrie-bw.de/en/article/news/antibiotics-for-the-prevention-of-malaria
  • Press release - 23/08/2010 12188_de.jpg

    Dr. Carsten Daub – team leader at the Bioinformatics Core Facility of RIKEN in Yokohama

    Dr. Carsten Daub a German bioinformatician who first studied chemistry at the TU Berlin did his doctoral degree in 2004 at the MPI of Molecular Plant Physiology in Potsdam Germany and after a two years post-doctoral training at the Karolinska Institutets Center or Genomics and Bioinformation in Stockholm Sweden joined the Genome Sciences Center at RIKEN in April 2006 on a five years contract.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/dr-carsten-daub-team-leader-at-the-bioinformatics-core-facility-of-riken-in-yokohama
  • Article - 23/08/2010 12144_de.jpg

    Signals that trigger symbiotic relationships

    Some fungi kill plants by wearing them down. Other fungi however are on friendly terms with plants. The research group led by Prof. Dr. Natalia Requena from the Karlsruhe Institute of Technology KIT investigates the molecular mechanisms that enable fungi and plants to initiate contact with each other. How do plants differentiate good from bad fungi? How do they manage to set up a functional and effective symbiotic relationship?

    https://www.gesundheitsindustrie-bw.de/en/article/news/signals-that-trigger-symbiotic-relationships
  • Press release - 15/08/2010

    Horizon Pharma - Nitec Pharma and Horizon Therapeutics combine businesses

    Nitec Pharma AG, a spin-off from Merck (Darmstadt, Germany) and Horizon Therapeutics, Inc. (USA) have announced the combination of their businesses to become Horizon Pharma, Inc. and the filing of a registration statement for a proposed initial public offering. The company’s Mannheim-based subsidiary, which is focused on the development and commercialisation of drugs for the treatment of pain and chronic inflammatory diseases, has been named…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/horizon-pharma-nitec-pharma-and-horizon-therapeutics-combine-businesses
  • Press release - 15/08/2010 Portrait of Dr. Stefan Fennrich

    The man who saved white rabbits

    When Stefan Fennrich received a telephone call asking for his opinion on replacing animal testing with in vitro human blood testing he was immediately thrilled by the idea. This is brilliant said the enthusiastic physician and biochemist from Tübingen. The call was from Professor Thomas Hartung and Albrecht Wendel from the University of Constance who came up with the idea of the PyroDetect assay which experts regard as a groundbreaking innovation…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-man-who-saved-white-rabbits
  • Press release - 15/08/2010

    High-performance microscopy system at the Institute of Zoology

    A new high-performance microscopy system funded by the German Research Foundation (DFG) will be in operation at the Institute of Zoology at the University of Heidelberg. The biologist Prof. Dr. Jochen Wittbrodt and his team will use the system to investigate central development stages in animals, in particular embryonic development processes that lead to the formation of a complete fish.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/high-performance-microscopy-system-at-the-institute-of-zoology
  • Press release - 15/08/2010 Decisions on the admission of applicants are also based on the results of interviews: The photo shows Dr. Bergmann with Dr. Dieter Brockmann, who is also a member of the Admission Committee.

    New Advanced Oncology Online Master Programme

    Ulm University is developing an innovative international postgraduate study programme in Advanced Oncology which will be launched at the beginning of the winter semester in October 2010. The four-semester part-time master study programme is geared towards practicing oncologists and scientists in the field of oncology qualifying them for leading positions in academic organisations oncology centres or in the pharmaceutical industry.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-advanced-oncology-online-master-programme
  • Press release - 14/08/2010 10938_de.jpg

    Data management and new simulation methods for the virtual liver

    Researchers at the Heidelberg Institute for Theoretical Studies HITS are part of the national Virtual Liver Network initiated and financed by the German Federal Ministry of Education and Research BMBF.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/data-management-and-new-simulation-methods-for-the-virtual-liver
  • Press release - 12/08/2010

    Glycotope Received Regulatory Approval for Glycooptimized and Fully Human Glycosylated Antibody CetuGEX™ and Enrolls First Patients in Clinical Trial

    Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX™ (GT-MAB 5.2-GEX) for the treatment of various solid cancers.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/glycotope-received-regulatory-approval-for-glycooptimized-and-fully-human-glycosylated-antibody-cetu
  • Article - 09/08/2010 10264_de.jpg

    Elara Pharmaceuticals

    The Heidelberg-based biotech company ELARA Pharmaceuticals is focused on the development of treatments of tumours through the inhibition of the hypoxia signalling pathway (HIF) and through the induction of apoptosis. The company’s lead candidate targets multiple myeloma, a cancer that arises in the plasma cells of the immune system.

    https://www.gesundheitsindustrie-bw.de/en/article/news/elara-pharmaceuticals
  • Article - 09/08/2010 Access to the catalytically active haem group (yellow) in a bacterial monooxygenase enzyme can be modified by introducing mutations into the two “hotspots” (red). The shape of the binding site in six highly selective mutants differs from the binding site of the naturally occurring enzyme (centre).

    Enzyme variants – designed on a virtual drawing-board

    Sometimes it needs no more than a single mutation to make an enzyme convert a substrate that it previously did not interact with. There is an art to finding an amino acid position in the enzyme that can be mutated and changed in a way that results in the required outcome. But if the researchers succeed in doing so, they are able to ‘teach’ the enzyme to only convert a specific substrate variant or produce only one specific product variant. The…

    https://www.gesundheitsindustrie-bw.de/en/article/news/enzyme-variants-designed-on-a-virtual-drawing-board
  • Article - 09/08/2010 The photo shows a green building.

    IBAM GbR - Enzymes, neurotransmitters and Greek mountain tea

    The Denzlingen-based company IBAM GbR offers solutions that enable faster and cost-effective drug discovery. IBAM GbR was spun off from the University of Freiburg and supports industrial customers in identifying biochemical targets of potential drugs or the modes of action of enzymes and second messengers in the central nervous system and other tissues. Over the last few years the companys managing director Dr. Rainer Knörle and his partner Dr.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/ibam-gbr-enzymes-neurotransmitters-and-greek-mountain-tea

Page 74 / 119

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 119
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search